Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Professors Kristian Helin and Trevor Graham elected as Fellows of the Academy of Medical Sciences
Professor Kristian Helin, Chief Executive and President at The Institute of Cancer Research, London, and Professor Trevor Graham, Director of the ICR’s Centre for Evolution and Cancer, have been awarded prestigious Fellowships for the Academy of Medical Sciences (AMS).
ICR saddened by death of Mike Ormerod
The ICR is saddened to learn of the death of Dr Mike Ormerod, who headed the ICR’s flow cytometry facility in Sutton in the 1980s.
Common genetic mutation allows cancer cells to gain extra chromosomes which help them survive
Scientists have found a genetic mutation that results in cancer cells being able to tolerate having an abnormal number of chromosomes – a condition which normally kills cells – allowing them to adapt to their environment and continue to grow.
Drugs targeting cell recycling could be used to suffocate cancer cells
Pancreatic cancers recycle resources to fuel their survival and growth, opening up the possibility of new treatments aimed at stopping them from doing so, scientists report.
New 3D structure could help design future drugs against cancer
A team of scientists has created a three-dimensional map showing how a small molecule with anticancer properties – called spliceostatin – can promote the killing of cancer cells.
A field rich for discovery: realising immunotherapy’s potential
Widely considered a revolutionary treatment, immunotherapy has become a powerful tool against cancer. On the International Day of Immunology, Gege Li looks at the progress we are making in our understanding of the immune landscape of cancer to develop more effective treatments for even more people with cancer.
Damaged DNA – wielding a double-edged sword against cancer
This DNA Day, we look at how our scientists are seeking to understand how cells respond to damage to DNA – and the tricks cancer uses to stay alive despite suffering genetic damage.
AI study 'exciting first step' towards improving post-treatment surveillance of lung cancer patients
Artificial intelligence (AI) could help guide the post-treatment surveillance of non-small cell lung cancer (NSCLC) patients and improve outcomes as a result, according to new research.
From bench to bedside and beyond: the team of scientists that transformed breast cancer treatment
A group of researchers from The Institute of Cancer Research and The Royal Marsden have won the prestigious AACR Team Science Award for breast cancer research. Hear from the winning team about their pioneering work and its impact.
AACR 2022: New 'killer' immunotherapy shows early promise in range of solid tumours
A new type of immunotherapy making use of the immune system’s ‘natural killer cells’ could offer potential against a range of cancers that can evade current treatments, early results from a phase I trial suggest.
AACR 2022: Team of scientists and clinicians wins global award for transforming breast cancer treatment
A group of UK clinical and non-clinical scientists working together across different areas of cancer research has won the AACR Team Science Award for work that has transformed treatment for many patients with breast cancer.
AI test could predict effective cancer drug combinations in less than two days
Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in as little as 24 to 48 hours.